Product Information
AMOX-CLAV 400-57 MG/5 ML SUSP is a generic product labeled by Micro Labs Limited, priced at $0.0562 per ML under NDC 42571016447. Its NADAC has been published 234 times since Apr 13, 2022.
FDA first approved this application on May 21, 2021.
Strength
400; 57 mg/5mL; mg/5mL
Manufacturer
Micro Labs LimitedNDC
42571016447
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
AMOXICILLIN; CLAVULANATE POTASSIUMApproval Type
Generic (ANDA)
FDA Application
ANDA205187FDA Approved
5/21/2021
On Market Since
7/1/2021
Pharmacological Classes
Price Statistics
The NADAC for AMOX-CLAV 400-57 MG/5 ML SUSP has been published 234 times since Apr 13, 2022, and over the history we have for it it has declined 26.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0562 per ML |
|---|---|
| All-time high | $0.0792 (Feb 15, 2023) |
| All-time low | $0.0539 (Jul 17, 2024) |
| 52-week high | $0.0661 |
| 52-week low | $0.0562 |
| Median price | $0.0629 |
| Average price | $0.0630 |
| Largest weekly change | +27.5% (Aug 21, 2024) |
| Weeks tracked | 234 |
| Tracking since | Apr 13, 2022 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Micro Labs Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Amoxicillin and Clavulanate Potassium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Penicillin-class Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AMOX-CLAV 400-57 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for AMOX-CLAV 400-57 MG/5 ML SUSP, manufactured by Micro Labs Limited, is $0.0562 per ML (NDC 42571016447), effective Sep 30, 2026.
How has the price of AMOX-CLAV 400-57 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for AMOX-CLAV 400-57 MG/5 ML SUSP has declined 26.9%. It has been tracked across 234 weekly CMS publications since Apr 13, 2022.
What are the highest and lowest recorded NADAC prices for AMOX-CLAV 400-57 MG/5 ML SUSP?
Since Apr 13, 2022, the NADAC for AMOX-CLAV 400-57 MG/5 ML SUSP has ranged from a low of $0.0539 (Jul 17, 2024) to a high of $0.0792 (Feb 15, 2023), with a median of $0.0629 per ML.
Are there cheaper alternatives to AMOX-CLAV 400-57 MG/5 ML SUSP?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as AMOX-CLAV 400-57 MG/5 ML SUSP in a comparable dosage form, but none are currently priced below it.
Who manufactures AMOX-CLAV 400-57 MG/5 ML SUSP?
AMOX-CLAV 400-57 MG/5 ML SUSP (NDC 42571016447) is labeled by Micro Labs Limited, and CMS classifies it as a generic product.